Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocation.
The effects of an n-3 PUFA-enriched diet on cardiac cell membrane phospholipid fraction compositions and associated protein kinase-C (PKC) translocation modification have never been studied in higher mammals. This is of importance since membrane fatty acid composition has been shown to influence PKC signalling pathways. In the present study, we have tested whether the incorporation of n-3 PUFA in cardiac membrane phospholipids correlated with changes in the fatty acid composition of diacylglycerols (DAG) and led to a differential translocation of PKC isoforms. Two groups of five dogs were fed the standard diet supplemented with palm oil or fish oil for 8 weeks. Dogs fed a fish oil-enriched diet showed a preferential incorporation of EPA and, to a lesser extent, of DHA, at the expense of arachidonic acid, in the circulating TAG, plasma phospholipids, erythrocyte phospholipids and cardiomyocyte phospholipid fractions. Analysis of 1,2-DAG fatty acid composition also indicated a preferential enrichment of EPA compared with DHA. Associated with these results, a reduction in the expression of PKC-delta and PKC-epsilon isoforms in the particulate fractions was observed whereas no effect was seen for PKC-alpha and PKC-zeta. We conclude that a fish oil-enriched diet induces a modification in fatty acid composition of cardiac membrane phospholipids, associated with a differential translocation of PKC isoforms. These results can be explained by the production of structurally different DAG that may participate in some of the protective effects of n-3 PUFA against various chronic diseases.
CERB, Centre de Recherches Biologiques, Baugy, F-18800, France.
Sébastien
S
Judé
Eric
E
Martel
Fanny
F
Vincent
Pierre
P
Besson
Charles
C
Couet
Gregory K
GK
Ogilvie
Michelle
M
Pinault
Catherine
C
De Chalendar
Philippe
P
Bougnoux
Serge
S
Richard
Pascal
P
Champeroux
Bertrand
B
Crozatier
Jean-Yves
JY
Le Guennec
D000818:Animals; D001692:Biological Transport; D015153:Blotting, Western / Q000379:methods; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage*; D019587:Dietary Supplements; D004285:Dogs; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage*; D005395:Fish Oils; D008297:Male; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism; D000073878:Palm Oil; D010743:Phospholipids / Q000097:blood*; D010938:Plant Oils; D051745:Protein Kinase C-delta / Q000378:metabolism*; D051744:Protein Kinase C-epsilon / Q000378:metabolism*; D011897:Random Allocation
D004042:Dietary Fats, Unsaturated; D015525:Fatty Acids, Omega-3; D005395:Fish Oils; D010743:Phospholipids; D010938:Plant Oils; D000073878:Palm Oil; D051745:Protein Kinase C-delta; D051744:Protein Kinase C-epsilon